Can one purchase nicotine pouches? Various businesses are promoting their marketing efforts. - The Authority has been directed to put forward a suggestion for a regulation aimed at safeguarding laborers from dangers resulting from radiation exposure by ionizing rays.
In the heart of Germany, a minty, fruity, or cocktail-flavored debate has ignited. We're talking about nicotine pouches, a small, cellulose-based substitute for traditional cigarettes that's gaining popularity, despite being officially banned from store shelves. Phil Morris Germany, among other tobacco giants, is pushing for legalization, arguing that these pouches could be a less harmful alternative for adults trying to quit smoking.
However, this argument isn't without controversy. Health researchers and politicians warn about the dangers, particularly for young individuals. The pouches, which deliver nicotine through the upper lip, lack tobacco but contain aromas, coming in various flavors like menthol, cinnamon, and fruits. In the US, the Food and Drug Administration (FDA) has approved the marketing of certain nicotine pouch products, seen as a boost for manufacturers.
The tobacco industry is undergoing a transformation. Major corporations are gradually moving away from cigarettes and exploring smoke-free products like e-cigarettes, tobacco heaters, and nicotine pouches. Philip Morris sold 644 million cans of its nicotine pouch brand, Zyn, in 2024, a 53% increase from the previous year.
Germany's classification of nicotine pouches as food has led to a peculiar situation. While they can't be sold in stores due to their nicotine content, they can be ordered online or obtained from black market vendors. Lobbyist Torsten Albig, from Philip Morris Germany, views this as an absurd contradiction: "A German retailer can't sell it, but the consumer can have it shipped from an EU country."
Philip Morris and other tobacco companies are hoping for legalization, maintaining that nicotine pouches can help adult smokers quit traditional cigarettes. However, this proposal has met with criticism from health experts and politicians. They argue that marketing these products as a less harmful alternative is hypocritical, given the tobacco industry's role in tobacco-related illnesses and deaths.
Critics also question the effectiveness of nicotine pouches as a cessation aid. While they can potentially help smokers transition, they are not approved as such by medical authorities. Long-term studies on their harmfulness are lacking, leaving their true impact uncertain.
The calls for a national regulation within tobacco law were made by consumer protection ministers in 2021, but no action has been taken since. The Federal Ministry of Food and Agriculture refers the issue to Brussels, advocating for a uniform EU approach and regulation.
While the debate continues, one thing is clear: nicotine pouches have become a contentious topic in German and European tobacco regulation. Their potential as a harm reduction strategy is balancing against concerns about youth access and addiction. As the regulatory landscape evolves, so too does the future of nicotine pouches in Germany.
Regardless of the ongoing debate, international tobacco companies like Phil Morris continue to advocate for the legalization of nicotine pouches. These companies argue that other smoke-free products, such as nicotine pouches, could serve as lesser neurotoxin alternatives for adults attempting to quit traditional cigarettes. However, critics challenge this perspective, pointing out that the tobacco industry's history of tobacco-related illnesses and deaths makes marketing nicotine pouches as less harmful questionable.
